Rocket Lab Corp’s recent filing unveils that its Director Saintil Merline unloaded Company’s shares for reported $0.33 million on Dec 19 ’25. In the deal valued at $65.00 per share,5,000 shares were sold. As a result of this transaction, Saintil Merline now holds 388,529 shares worth roughly $30.13 million.
Then, Olson Jon A sold 15,000 shares, generating $1,022,773 in total proceeds. Upon selling the shares at $68.18, the Director now owns 360,835 shares.
Before that, MERLINE A SAINTIL bought 5,000 shares. Rocket Lab Corp shares valued at $299,600 were divested by the Director at a price of $59.92 per share.
Needham reiterated its Rocket Lab Corp [RKLB] rating to a Buy in a research note published on November 12, 2025; the price target was $63. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in mid October with a ‘”an Outperform”‘ rating. Craig Hallum began covering RKLB with “Hold” recommendation on July 28, 2025.
Price Performance Review of RKLB
On Monday, Rocket Lab Corp [NASDAQ:RKLB] saw its stock jump 9.97% to $77.55. Over the last five days, the stock has gained 39.96%. Rocket Lab Corp shares have risen nearly 238.35% since the year began. Nevertheless, the stocks have risen 204.48% over the past one year. While a 52-week high of $73.97 was reached on 12/22/25, a 52-week low of $14.71 was recorded on 04/07/25.
Levels Of Support And Resistance For RKLB Stock
The 24-hour chart illustrates a support level at 74.05, which if violated will result in even more drops to 70.55. On the upside, there is a resistance level at 79.75. A further resistance level may holdings at 81.95.
How much short interest is there in Rocket Lab Corp?
A steep rise in short interest was recorded in Rocket Lab Corp stocks on 2025-11-28, dropping by -5.73 million shares to a total of 45.2 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 50.94 million shares. There was a decline of -12.68%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 25, 2025 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $28 price target.
